search icon

    Market Snapshot

    • S&P Futures

      4,132.25

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,101.5

    blog search icon

    Finch Therapeutics Group, Inc.

    (NASDAQ:FNCH)

    $2.41

    $0.15

    6.64%

    Finch Therapeutics Group, Inc. Chart

    FNCH Stock Price Today

    Finch Therapeutics Group, Inc. (FNCH) stock rallied over 6.64% intraday to trade at $2.41 a share on NASDAQ. The stock opened with a gain of 5.70% at $2.38 and touched an intraday high of $2.55, rising 6.64% against the last close of $2.26. The stock went to a low of $2.23 during the session.

    Stock Snapshot

    $2.26

    Prev. Close

    112.62 Million

    Market Cap

    $2.23

    Day Low

    $2.38

    Open

    47.53 Million

    Number of Shares

    $2.55

    Day High

    -

    P/E ratio

    -1.45

    EPS (TTM)

    2.25

    Cash Flow per Share

    1.24

    Free Float in %

    4.63

    Book Value

    47,434

    Volume

    Finch Therapeutics Group, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$2.38$2.55$2.23$2.4147,433
    2022-08-05$2.28$2.37$2.12$2.2668,200
    2022-08-04$2$2.38$2$2.2235,400
    2022-08-03$1.88$2.103$1.82$2.0341,100
    2022-08-02$1.78$2.09$1.74$1.992,000
    2022-08-01$1.89$1.95$1.85$1.8520,900
    2022-07-29$2.04$2.04$1.91$1.9529,200
    2022-07-28$2.01$2.09$1.95$1.9522,600
    2022-07-27$2.01$2.06$1.92$2.0218,700
    2022-07-26$2.08$2.08$1.85$1.9942,500

    Contact Details

    200 Inner Belt Road
    Suite 400
    Somerville, MA 02143
    United States

    Webiste:FNCH

    617 229 6499

    Company Information

    Employees-

    Beta-

    Sales or Revenue15.33 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Finch Therapeutics Group, Inc. (FNCH) stock price?

    Finch Therapeutics Group, Inc. (NASDAQ: FNCH) stock price is $2.41 as of the last check on Monday, August 8. During the trading session, FNCH stock reached the peak price of $2.55 while $2.23 was the lowest point it dropped to.

    icon

    FNCH's industry and sector of operation?

    The NASDAQ listed FNCH is part of Biotechnology industry that operates in the broader Health Care sector. Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.

    icon

    Who are the executives of FNCH?

    Dr. Mark Burnham Smith Ph.D.
    CEO & Director
    Mr. Marc B. Blaustein C.F.A., CFA, MPP
    Chief Operating Officer
    Mr. Joseph D. Vittiglio Esq., J.D.
    Chief Bus. & Legal Officer and Corp. Sec.
    Mr. Gregory D. Perry
    Chief Financial Officer

    icon

    What is the FNCH stock price today?

    FNCH stock traded closed the last session at $2.41, which is $0.15000000000000036 or 6.637168141592936% lower than its previous close of $2.26. FNCH's current trading price is 40.8% lower than its 52-week high of $17.39 where as its distance from 52-week low of 1.71% is -86.14%.

    icon

    How many employees does FNCH have?

    Number of FNCH employees currently stands at -. FNCH operates from 200 Inner Belt Road, Suite 400, Somerville, MA 02143, United States.

    icon

    Link for FNCH official website?

    Official Webiste of $FNCH is: https://www.finchtherapeutics.com

    icon

    How do I contact FNCH?

    FNCH could be contacted at FNCH operates from 200 Inner Belt Road, Suite 400, Somerville, MA 02143, United States, or at phone #617 229 6499 and can also be accessed through its website.

    icon

    How many shares of FNCH are traded daily?

    FNCH stock volume for the day was 47,434 shares while in the previous session number of FNCH shares traded was 47,433 . The average number of FNCH shares traded daily for last 3 months was 121.63 Thousands.

    icon

    How much did FNCH change today?

    The percentage change in FNCH stock occurred in the recent session was 6.637168141592936% while the dollar amount for the price change in FNCH stock was $0.15000000000000036.

    icon

    What price range FNCH stock been trading in?

    In the recent session, the day high for FNCH stock was $2.55 while the low for FNCH stock touched on the day was $2.23.

    icon

    What is the market cap of FNCH currently?

    The market value of FNCH currently stands at 112.62 Million with its latest stock price at $2.41 and 47.53 Million of its shares outstanding.